ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

Mol Med · 2025 · PMC12153148 · PMID 40500731

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For every comparison P < 0.05 was considered statistically significant and, P < 0.01 highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.